Based on the Chromocell Therapeutics Corporation stock forecast from 1 analysts, the average analyst target price for Chromocell Therapeutics Corporation is USD 8.50 over the next 12 months. Chromocell Therapeutics Corporation’s average analyst rating is Strong Buy. Stock Target Advisor’s own stock analysis of Chromocell Therapeutics Corporation is Neutral, which is based on 0 positive signals and 0 negative signals. At the last closing, Chromocell Therapeutics Corporation’s stock price was USD 0.64. Chromocell Therapeutics Corporation’s stock price has changed by +0.30% over the past week, -2.89% over the past month and 0% over the last year.
Analyst Ratings
Target Price Action
Rating Action
Analyst
Rating
Price
Date
Stock Target Advisor's Analysis
This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.
What to like
There is nothing we particularly like
What not to like
There is nothing we particularly dislike
Add to Watchlists
loading..
Download Confirmation
Premium customers can only download records visible on the current page view, while Platinum customers can download the first 1000 records.
Paid-only feature
CSV downloads are only available for paying customers.
Thank you for Sharing your Stock Targets for CHRO !
Loading...
Please login to proceed
Sorry - extended search is only available for registered users.
